| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.075 | 0.4 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |